SHH and pancreatic neoplasm: Finally, combination treatments targeting both the stroma and the cancer cells with Shh inhibitor IPI-926, together with chemotherapy drug gemcitabine, has shown depletion of stroma and increased drug delivery in a preclinical mouse model of pancreatic cancer proving efficacy of combinatorial strategy against both cancer cells and stroma [9, 34].